Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Biotech
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
If the layoff rate remains constant, one could expect 252 workforce reductions by the end of the year—a 27% percentage point jump from 2024.
Gabrielle Masson
Oct 3, 2025 4:30pm
Novo vs. KBP Chapter 2: 'Anomalous' trial results
Oct 2, 2025 3:00am
Novo calls off $598M Heartseed collab, citing 'strategic reviews'
Sep 30, 2025 1:55pm
One-third of data collected in trials may be unnecessary: study
Sep 19, 2025 11:01am
Lilly rounds out orforglipron data ahead of obesity filings
Sep 17, 2025 9:00am
Novo pushes ahead with amylin after seeing ph. 3 tolerability
Sep 16, 2025 8:12am